08/19/2024
4:53 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:59 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:07 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:12 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:17 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:23 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/30/2024
6:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
5:04 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
3:32 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
5:11 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
6:17 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:14 PM | Day One Biopharmaceuticals (Subject)
Ramasastry Saira (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
7:36 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:29 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
7:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
7:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
5:44 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:48 PM | Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:24 PM | Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:27 PM | Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:31 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:13 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:17 PM | Day One Biopharmaceuticals (Issuer)
Gladstone Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
5:21 PM | Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:02 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
5:11 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:15 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:18 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:27 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:21 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:29 PM | Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:34 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:43 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
5:13 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:35 PM | Day One Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
3:30 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
5:44 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:48 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
7:01 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:36 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here. |
03/26/2024
5:09 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:24 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:55 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:48 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:36 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:14 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:26 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
4:51 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:50 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024
4:19 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:22 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:01 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/19/2024
4:09 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
7:25 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:25 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:29 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:17 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:22 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:30 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:06 PM | Day One Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/17/2023
5:20 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:26 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:30 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:33 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
6:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
7:39 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/16/2023
5:08 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
5:24 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
3:48 PM | Day One Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
3:30 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
7:12 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
3:02 PM | Access Industries Holdings LLC (Reporting)
ACCESS INDUSTRIES MANAGEMENT, LLC (Reporting)
AI Day1 LLC (Reporting)
Blavatnik Len (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
4:28 PM | Day One Biopharmaceuticals (Filer)
| Form S-3ASR | |
09/11/2023
7:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
